Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Figlin

Showing results (1-10 of 89) with videos related to

Pageof 9
Sort By:
Seminars in Hematology|July 1, 1989
Biotherapy in clinical practiceR A Figlin
The Cancer Journal From Scientific American|February 11, 1998
Renal cell carcinoma and interleukin-2: what are the endpoints?R A Figlin
The Cancer Journal From Scientific American|February 24, 2000
Renal cell carcinoma: current status and future plansR A Figlin
Oncology Nursing Forum|November 1, 1987
Biotherapy with interferon in solid tumorsR A Figlin
Seminars in Hematology|April 1, 1992
Cancer immunotherapy using tumor-infiltrating lymphocytesR A Figlin
Seminars in Oncology|December 1, 1988
Biotherapy with interferon--1988R A Figlin
The Journal of Urology|January 23, 1999
Renal cell carcinoma: management of advanced diseaseR A Figlin
Chest|December 1, 1994
A phase 3 randomized trial of immediate combination chemotherapy vs delayed combination chemotherapy in patients with completely resected stage II and III non-small cell carcinoma of the lungR A Figlin, S Piantodosi
Cancer Treatment Reports|May 1, 1985
Phase II trial of alpha-lymphoblastoid interferon given weekly as treatment of advanced breast cancerG P Sarna, R A Figlin
World Journal of Urology|June 15, 2000
Intratumoral interleukin 2 for renal-cell carcinoma by direct gene transfer of a plasmid DNA/DMRIE/DOPE lipid complexD M Hoffman, R A Figlin
Pageof 9

Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
Seminars in Hematology|July 1, 1989
Biotherapy in clinical practiceR A Figlin
The Cancer Journal From Scientific American|February 11, 1998
Renal cell carcinoma and interleukin-2: what are the endpoints?R A Figlin
The Cancer Journal From Scientific American|February 24, 2000
Renal cell carcinoma: current status and future plansR A Figlin
Oncology Nursing Forum|November 1, 1987
Biotherapy with interferon in solid tumorsR A Figlin
Seminars in Hematology|April 1, 1992
Cancer immunotherapy using tumor-infiltrating lymphocytesR A Figlin
Seminars in Oncology|December 1, 1988
Biotherapy with interferon--1988R A Figlin
The Journal of Urology|January 23, 1999
Renal cell carcinoma: management of advanced diseaseR A Figlin
Chest|December 1, 1994
A phase 3 randomized trial of immediate combination chemotherapy vs delayed combination chemotherapy in patients with completely resected stage II and III non-small cell carcinoma of the lungR A Figlin, S Piantodosi
Cancer Treatment Reports|May 1, 1985
Phase II trial of alpha-lymphoblastoid interferon given weekly as treatment of advanced breast cancerG P Sarna, R A Figlin
World Journal of Urology|June 15, 2000
Intratumoral interleukin 2 for renal-cell carcinoma by direct gene transfer of a plasmid DNA/DMRIE/DOPE lipid complexD M Hoffman, R A Figlin
Pageof 9